Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Alain Depierre"'
Autor:
Denis Moro-Sibilot, Christophe Hennequin, Pierre Mouillefarine, Marc Riquet, Cécile Le Péchoux, Jean-Yves Douillard, Gérard Zalcman, Fabien Vaylet, Annie Giniès, Elisabeth Quoix, Alain Depierre, Bernard Milleron, Benjamin Besse, Jean-François Regnard, Sylvie Guillo, Clotilde Séblain-El Guerche
Publikováno v:
Oncologie. 9:800-809
Introduction La mise a jour des recommandations pour la pratique clinique (RPC) pour le traitement perioperatoire des patients atteints d’un cancer bronchique non a petites cellules resecable d’emblee, operables a ete elaboree par la Federation n
Autor:
Didier Debieuvre, S. Hominal, Radj Gervais, Jean-Louis Pujol, Olivier Molinier, Jean-Luc Breton, Dominique Tonelli, Elisabeth Quoix, Fouad Namouni, Alain Depierre, Bernard Milleron
Publikováno v:
Journal of Thoracic Oncology. 1(4):328-334
Introduction We designed this phase II trial to evaluate the efficacy and safety of weekly paclitaxel in combination with monthly carboplatin as first-line treatment in elderly patients with advanced non-small cell lung cancer (NSCLC). Methods Main e
Autor:
Denis Moro-Sibilot, Denis Braun, Virginie Westeel, Bernard Lebeau, Elisabeth Quoix, Alain Depierre, Bernard Milleron
Publikováno v:
Chest. 128:1442-1447
Background Pathologic complete response (CR) to preoperative chemotherapy has been shown to be a strong prognostic factor in resected non-small cell lung cancer (NSCLC). This preoperative setting offers the opportunity to evaluate the clinical predic
Autor:
Jean-Yves Douillard, Andrea Bezjak, Dongsheng Tu, Katherine Hann, Armando Santoro, Daniel Betticher, Luis Paz-Ares, Frances A. Shepherd, Christian Peschel, Maurizio Voi, Jeffrey S. Humphrey, Andrew Arnold, Jeffrey Crawford, Natasha B. Leighl, Lesley Seymour, Jacek Jassem, Susan M. Galbraith, Alain Depierre, Ulrich Gatzemeier
Publikováno v:
Journal of Clinical Oncology. 23:2831-2839
Purpose To determine whether BMS-275291, a broad-spectrum matrix metalloproteinase inhibitor (MMPI), added to systemic chemotherapy improved survival in advanced non–small-cell lung cancer (NSCLC). In early phase studies, BMS- 275291 was not associ
Autor:
R. Kessler, J.-L. Breton, D. Debieuvre, Xavier Quantin, Denis Moro-Sibilot, B. Milleron, D. Spaeth, P. Rebattu, Alain Depierre, J.L. Pujol, C. Clary, Radj Gervais, D. Braun, D. Castera, P.J. Souquet, H. Janicot, Etienne Lemarié, Jean-François Morère
Publikováno v:
Annals of Oncology. 16:602-610
Background This multicenter, randomized, phase III study compared the efficacy, including progression-free survival (PFS), and safety of gemcitabine–docetaxel (GD) combination versus cisplatin–vinorelbine (CV) in the treatment of advanced non-sma
Autor:
Didier Debieuvre, J.-L. Breton, Bernard Lebeau, P. Clouet, Bernard Milleron, Fabien Vaylet, Gérard Zalcman, Alain Depierre, J. M. Brechot, D. Moro-Sibilot, A. Vergnenegre, Etienne Lemarié, E. Quoix, J.L. Pujol, A. Ducolone
Publikováno v:
Annals of Oncology. 15:38-44
Background The survival benefit associated with first-line chemotherapy in advanced lung cancer led to the need for second-line chemotherapy. Docetaxel (Taxotere®) has proven efficacy in both settings. This study evaluated the safety and efficacy of
Autor:
Alain Depierre, Virginie Westeel
Publikováno v:
American Journal of Respiratory Medicine. 2:477-490
Among all nonmetastatic non-small-cell lung cancer (NSCLC) patients, the best survival rates are observed in patients who undergo surgery. Nevertheless, 5-year survival rates vary between 20% and 60% depending on the stage of the disease. Several com
Autor:
Alain Depierre, François Blanchon, Bernard Milleron, Marie-Claude Level, Etienne Lemarié, Jeanne-Marie Bréchot, Sylvie Chevret, Jean-Michel Rodier, D. Moro-Sibilot, François-Xavier Lebas, B. Lebeau, Nadine Paillot, Pascal Leclerc, Jean Clavier, Michel Monchâtre, Anne Villeneuve, Pascal Foucher, Virginie Westeel, Elisabeth Quoix, Sylvie Gouva, Claude Chastang, D. Coëtmeur, Denis Braun, Philippe Terrioux, Jean-Luc Breton, H. Janicot, Luc Thiberville
Publikováno v:
Journal of Clinical Oncology. 20:247-253
To evaluate whether preoperative chemotherapy (PCT) could improve survival in resectable stage I (except T1N0), II, and IIIA non-small-cell lung cancer (NSCLC).A randomized trial compared PCT to primary surgery (PRS). PCT consisted of two cycles of m
Autor:
Petr Zatloukal, Rodryg Ramlau, Maciej Krzakowski, H. Karnicka-Mlodkowska, K. Krawczyk, Mary O'Brien, Jacek Jassem, L. Novakova, Alain Depierre, Etienne Lemarié, W. Hartmann
Publikováno v:
Annals of Oncology. 12:1375-1381
A randomized phase II trial of oral vs. intravenous (i.v.) vinorelbine was designed to determine the efficacy and safety of oral vinorelbine with an intrapatient dose escalation in previously untreated patients with advanced non-small-cell lung cance
Autor:
Jean-Léon Lagrange, Westeel, J.-Y. Douillard, Etienne Lemarié, Denis Moro-Sibilot, Bazelly B, Ranfaing E, Thiberville L, Grivaux M, J. M. Brechot, Stoebner-Delbarre A, Alain Depierre, Vergnon Jm, Le Chevalier T, Fabien Vaylet, Etienne Bardet, Bernard Milleron, Pierre Baldeyrou, Astoul P, P. Jacoulet, Alain Rivière, J.-L. Breton, Dominique Spaeth, Pierre-Jean Souquet, Martinet Y, Quoix Ae, Khalil A, Emmanuel Touboul, Theobald S, Gilbert Massard, J.L. Pujol, Hélène Sancho-Garnier, Marianne Paesmans
Publikováno v:
Cancer/Radiothérapie. 5:425-444
Context The 'Standards, Options and Recommendations' (SOR) project, started in 1993, is a collaboration between the Federation of the French Cancer Centres (FNCLCC), the 20 French cancer centres and specialists from French public universities, genera